Inter-molecular heterologous mitochondrial DNA (mtDNA) recombination is known to occur in yeast and plants. Nevertheless, its occurrence in human cells is still controversial. To address this issue we have fused two human cybrid cell lines, each containing a distinct pathogenic mtDNA mutation and specific sets of genetic markers. In this hybrid model, we found direct evidence of recombination between these two mtDNA haplotypes. Recombinant mtDNA molecules in the hybrid cells were identified using three independent experimental approaches.
Introduction
MtDNA recombination has been well documented in plants, fungi, protists (1) , and invertebrates (2) , and the activity of enzymes involved in homologous recombination has been identified in mammalian mitochondria (3) . However, despite ample evidence of intra-molecular mtDNA recombination (4, 5) , the existence of inter-molecular mtDNA recombination in mammalian cells is still controversial, since most studies are based on indirect evidence derived from statistical analyses of mtDNA sequence data (6) (7) (8) .
Recently, inter-molecular heterologous recombination between paternal and maternal mtDNA molecules has been reported in a patient suffering from a form of mitochondrial myopathy, who had a unique case of biparental inheritance of skeletal muscle mtDNA (9) .
However, except for these very rare cases, recombination events occurring in the normal homoplasmic environment established by maternal uniparental inheritance would go undetected. Therefore, to study mtDNA recombination in human cells we have generated a hybrid cell culture model by fusing two cell lines with similar nuclear background, each harboring a distinct homoplasmic pathogenic mutation in an mtDNA polypeptide-coding gene. Since each mutation individually abolished mitochondrial oxidative phosphorylation, this model allowed us to select for hybrids where mitochondrial function was rescued by the functional interaction among the mutant genomes. At the same time, the mutations provided us with appropriate genetic markers to detect mtDNA recombination between the two species of mutant mtDNA.
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Results
Hybrid cells
A scheme of the strategy used for generating the hybrids is shown in figure 1 . We have utilized two lines of cytoplasmic hybrids (cybrids) derived from human ρ 0 143B/206 osteosarcoma cells lacking mtDNA (10) . One line was repopulated with mtDNA from a patient harboring a G6930A transition (11) creating a stop-codon in the gene encoding cytochrome c oxidase subunit I (MTCO1). Cybrids containing homoplasmic MTCO1 mutant (CO1MT) mtDNA were completely devoid of MTCO1 protein, lacked cytochrome c oxidase (COX) activity, and were unable to perform oxidative phosphorylation (12) .
The second cybrid line was repopulated with mtDNA from a patient harboring a 4-bp deletion of mtDNA nucleotides 14787-14790, which causes a frame-shift in the gene encoding cytochrome B (MTCyB), resulting in a truncated protein (13) . Cybrids homoplasmic for the MTCyB mutation (CyBMT) were completely defective in complex III (ubiquinol-cytochrome c oxidoreductase) activity and lacked oxidative phosphorylation (14) . CO1MT cybrids were stably transfected with a plasmid conferring resistance to the antibiotic hygromycin. CyBMT cybrids were stably transfected with a plasmid conferring resistance to the antibiotic puromycin. CO1MT
and CyBMT cybrids were fused and the resulting hybrids were selected in puromycin plus hygromycin.
Both CO1MT and CyBMT cybrids were unable to grow in medium without uridine and pyruvate because they lacked a functional mitochondrial respiratory chain (10) . Therefore, after a recovery period in normal medium, we grew hybrid cells in selective medium lacking uridine and pyruvate to select for hybrid clones with restored mitochondrial respiratory chain. Resistant hybrid clones were obtained with selection starting 10 days after fusion, and there was no 
MtDNA haplotypes
We determined the relative proportions of each mtDNA species (i.e., CO1MT and CyBMT mtDNAs) in the hybrid clones by restriction fragment length polymorphism (RFLP) analyses of PCR-amplified mtDNA. The G6930A transition in the MTCO1 gene, in combination with a mismatch primer, creates a novel AluI site (11) . The 4-bp deletion at nucleotides 14787-14790 in the MTCyB gene eliminates a naturally occurring AseI site (14) (Fig. 2A ).
Every clone analyzed harbored a mixture of the two mutant mtDNAs. Theoretically, if each hybrid clone harbored a heteroplasmic mixture of only two species of mtDNA, CO1MT and
CyBMT, the sum of these two species should account for 100% of the mtDNA genomes contained in a clone. Furthermore, since the AluI and the AseI sites are linked loci in the CO1MT haplotype, the relative proportions of these two genetic markers should always be equal.
Likewise, the relative proportion of AluI negative and AseI negative mtDNA derived from
CyBMT should coincide. Instead, we found that in the hybrid clones there was a discrepancy in (Fig. 2B,C) . In a total of 23 clones analyzed, the average discrepancy was 10% (standard deviation, ± 8%).
In order to identify additional genetic markers that could distinguish between CO1MT and
CyBMT mtDNA, we sequenced a portion of the D-loop region from both parental cybrids.
Among several nucleotide variations in this region, we identified a C16278T transition in the CO1MT mtDNA creating a novel EcoRV site. Using primers P5 and P6 (Fig. 3A) we amplified a 
Recombinant mtDNA molecules
In order to characterize recombinant mtDNA species at the single molecule level, we generated long-PCR products from two hybrid clones (clones 13-11 and 20-1), encompassing both the AluI site (associated with CO1MT) and the AseI site (associated with CyBMT) to be subcloned and sequenced. We first amplified long mtDNA fragments from nucleotide 6744 to 14840 and from nucleotide 14747 to 6960. However, we failed to subclone these fragments in E.coli, presumably because they contained a "poison sequence" in and around the MTCyB gene that cannot be subcloned with standard techniques (15, 16) . Finally, we succeeded in amplifying and subcloning a 7386 mtDNA fragment from nucleotide 16144 to 6960, encompassing the AluI site and the EcoRV site (associated with CO1MT; Fig. 3A ). Among 12 subclones, which were analyzed by RFLP and by direct sequencing, we identified two recombinant subclones that did not contain the AluI site but contained the EcoRV site, and one recombinant subclone containing the AluI site but not the EcoRV site (Fig. 3B ). To exclude that these recombinant subclones were the result of a long-PCR artifact, we repeated the same amplification and cloning procedures using as starting templates genomic DNA from CO1MT and CyBMT parental cybrids mixed in equal proportions. We analyzed 54 subclones from this negative control amplification and none showed discrepancies between the mtDNA markers.
We sequenced the three recombinant mtDNA subclones and compared them to the two parental mtDNA. Including the AluI and the EcoRV sites there were twenty polymorphic markers that distinguished the two parental mtDNAs. Based on these polymorphisms, we CyBMT differed in each of them (Fig. 3C ).
To obtain hybrid clones enriched for recombinant mtDNA we subjected hybrid clones 13-11 and 20-1, which had a high level of discrepancy between the proportion of AluI postive and AseI positive mtDNA, to prolonged treatment with ethidium bromide. By decreasing the mtDNA copy-number, ethidium bromide increases the likelihood of skewed mitotic segregation of the mtDNAs in dividing cells (17). After three weeks of ethidium bromide treatment (50 ng/ml), cells were subcloned and mtDNA was allowed to repopulate the cells.
Southern hybridization was used to test whether recombinant molecules were detectable with another method. We analyzed 13 ethidium bromide treated hybrid subclones and the parental cybrids. MtDNA was digested with both EcoRV and AseI and probed with an mtDNA fragment spanning nucleotides 15494-16255 and encompassing a region between the polymorphic EcoRV and AseI sites. Figure 4 shows a Southern hybridization experiment where recombinant mtDNA was detected. As anticipated, we identified two major bands: one of 3910 bp corresponding to
CyBMT mtDNA and another of 1492 bp corresponding to CO1MT mtDNA ( Fig. 4A and 4B top panel). All the hybrid subclones contained both bands, indicating that they were heteroplasmic.
In two subclones (13-11-eb2 and 13-11-eb1), there were prominent bands that were not seen in the parental cybrids, corresponding to the 3407 bp and the 1995 bp fragments derived from mtDNA recombination occurring between the polymoprphic EcoRV and AseI sites. To confirm the identity of these bands the blot was stripped and reprobed with an mtDNA fragment spanning nucleotides 13714-14749 that did not encompass the region between the polymorphic EcoRV and AseI sites (Fig. 4A ). As expected, with this probe the 1995 bp recombinant band disappeared 9 whereas the 3407 bp one remained (Fig 4B, bottom panel) . By phosphorimager determination the relative amounts of the two recombinant bands were approximately 10% of the total mtDNA.
These proportions were very close to the proportions of recombinant mtDNA estimated by PCR-RFLP in the same subclones. Two other subclones (20-1-eb11 and 20-1-eb5) contained lower amounts of the recombinant bands (at or below 1% of the total mtDNA). Table 1 The selection in medium without uridine eliminated all the subclones that contained homoplasmic mutant mtDNA and those that had become ρ 0 . Furthermore, we found no clones with proportions of AluI positive (CO1MT) mtDNA higher than 20% in this medium, suggesting that the G6930A COI mutation is more detrimental for oxidative phosphorylation than the CyB mutation. In the presence of uridine, approximately 50% of the clones had become ρ 0 , and several homoplasmic CO1MT or CyBMT clones were identified.
In all heteroplasmic subclones, the proportion of AseI positivity exceeded the proportion of AluI positivity (Fig. 5A) , indicating that the population of double wild type recombinant molecules (AseI positive, AluI negative) exceeded that of the double mutant molecules (AluI positive, AseI negative) (Fig. 5B) . 
Discussion
There is evidence that supports the concept that human mitochondria possess some of the enzymatic components necessary for homologous recombination (3, 18) and that mtDNA can undergo intra-molecular recombination (4, 5) . However, the identification of inter-molecular mtDNA recombination has been extremely difficult. Recombination within heteroplasmic cells may not result in a detectable haplotype variant unless two distinct non-allelic mutations, coexisting in the same mitochondrion but in different mtDNAs, give rise to novel molecules. In addition, human mtDNA inter-molecular recombination may be an extremely rare event.
Our hybrid human cell system provides an ideal setting to investigate the existence of intermolecular mtDNA recombination, because it involves mtDNA markers that can easily be recognized by RFLP analyses. We found that the majority of hybrid clones harbored recombinant molecules, which represented a significant proportion of the total mtDNA pool, and that the amount of recombination was highest in those clones where the two parental molecules had segregated in similar proportions. This observation fits a bimolecular reaction model where the probability that two distinct alleles recombine is proportional to the product of the frequency of each allele (i.e, probability of recombination ∝ %CO1MT x %CyBMT).
Based on the PCR-RFLP quantification, in the hybrid clones there was a prevalence of AluI negative (i.e., CO1 wild type) and AseI positive (i.e, CyB wild type) alleles (Fig. 2E, 5 ). It is possible that, when mtDNA recombination took place the growth conditions resulted in a growth advantage for cells containing these recombinant double wild type alleles over those containing a high proportion of mutant alleles. However, there was no apparent correlation between the beginning of metabolic selection and the proportion of double wild type recombinant molecules. For example, in hybrid clone 20-1, which had one of the highest proportions of double wild type recombinant molecules (Fig. 2B,C) , the metabolic selection did not start until day 20 after fusion.
After this long time of recovery, the hybrid clones had already established a full complement of mtDNA molecules. Alternatively, the prevalence of double wild type recombinant mtDNA molecules could result from a replicative advantage of these mtDNAs over the double mutant ones.
The prolonged ethidium bromide treatment of heteroplasmic hybrid clones in the absence of selection resulted in numerous clones that had lost their mtDNA or that were homoplasmic for one of the two parental mutant mtDNAs. This indicates that the treatment effectively lowered mtDNA copy number resulting in skewed mtDNA segregation. However, we did not isolate any clones that contained purely recombinant mtDNA, such as homoplasmic AluI positive AseI negative or vice versa. It appears to be very difficult to separate recombinant molecules from the parental ones. This observation supports the following model to explain the dynamic of mtDNA recombination in the hybrids (Fig. 6) . As previously shown, upon cell fusion cybrids undergo a rapid and dynamic reshaping of the mitochondrial network, characterized by membrane fusion with exchange of diffusible proteins (19) . Cybrid mtDNA is thought to be organized in discrete clusters of fewer than 8 molecules which are physically assembled and function as "replicative units", also known as nucleoids (20, 21) . Earlier studies suggested that nucleoids deriving from different human cybrids do not mix (20) . Recently, it was shown that in human cultured cells nucleoids move in a constrained random walk within the mitochondria and, during this motion, they constantly fuse and split (22) . The occurrence of mtDNA recombination in our hybrids indicates that nucleoids from the parental cybrids must have come in very close physical contact to exchange genetic material. Therefore, we propose that after mitochondrial fusion nucleoids are 12 subject to remodeling. During mtDNA replication, only recombination occurring in mixed nucleoids will result in novel mtDNA molecules. It follows that rearranged nucleoids would generate novel species of nucleoids containing a mixture of parental and recombinant mtDNA.
Upon cell division, such novel nucleoids become segregated in daughter cells. The ethidium bromide treatment of hybrid clones presumably resulted in mtDNA depletion to the level of a single nucleoid per cell. Since each nucleoid containing recombinant mtDNA must also contain parental mtDNA, upon mtDNA repopulation cells will harbor a heteroplasmic mix of parental and recombinant mtDNA.
We have shown that when it is investigated using a system with appropriate genetic markers, Starting on the third day post-fusion, hybrid cells were selected with both puromycin and hygromycin B. After 10, 13, 17, and 20 days post-fusion, nutritional selection of the hybrids was initiated in medium without pyruvate and uridine supplemented with 10% dialysed FBS.
Colonies grown in the nutritional selection medium were cloned by the cylinder method and expanded in the same medium as above. Two hybrid clones (20-1 and 13-11) were treated with Oxygen consumption in the hybrids was measured on intact cells with and without 2 µM of the protonophore carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) in an oxygraph chamber equipped with a Clark-type electrode as described (12) .
MtDNA analyses:
The sequences of mtDNA primers in figure 3 were ( The relative proportions of the G6930A mutation in MTCO1 and the 14787-14790 microdeletion in MTCytB were determined in each hybrid clone by PCR-RFLP analysis as described (11, 14) using P1-P2 and P3-P4 primers sets respectively (Fig. 3) . Briefly, amplified mtDNA fragments were radiolabeled by the "last cycle hot" technique (23), digested with AluI (for the G6930A mutation) or AseI (for the 14787-14790 micro-deletion), separated on a 12%
polyacrylamide gel, and quantified with a Cyclone phosphorimager using the OptiQuant software (Hewlett Packard).
For the sequencing of a fragment of the D-loop region from both parental mtDNA haplotypes, PCR amplification was performed using the P5-P6 primer set. Both strands of the resulting 266-base pair fragments were sequenced using an ABI 3700 automated sequencer. Quantification of the relative proportion of the C16278T polymorphism in the D-loop of the hybrids clones was performed on EcoRV digestion of PCR products amplified with the P5-P6 primer set and radiolabeled with the "last cycle hot". The 7386 bp long mtDNA fragments encompassing both the G6930A and C16278T mutations were amplified with P2-P5 primers using the Expand Long
Template System (Roche) according to the manufacturer's protocol, except that the annealing 16 temperature was 61°C. PCR products were subcloned using the TOPO XL PCR Cloning Kit (Invitrogen). Sequencing of the long-PCR subclones was performed using the M13 forward and M13 reverse primers and a series of internal mtDNA primers spanning the entire fragment. PCR-RFLP analyses of the subclones to identify the G6930A and C16278T mutations were performed as described above.
Southern blot analysis of mtDNA was performed as described (24) . In brief, approximately 10 µg of total DNA were digested with the restriction enzymes EcoRV and AseI. DNA fragments were separated in a 0.8% agarose gel and transferred to a ZetaProbe membrane were obtained after mtDNA depletion with ethidium bromide for 20 days followed by mtDNA repopulation in the presence (filled diamonds) or in the absence of uridine (empty circles). A)
The relative proportions of AluI+ and AseI+ mtDNA were measured by PCR-RFLP (as in figure   2 ) and plotted against each other. The dashed line represents the expected distribution of mtDNA alleles in the hybrid subclones in the absence of mtDNA heterologous recombination (such as in the mixing experiment of figure 2E) . B) In the hypothetical absence of heterologous recombination R′ = R′′ = 0, so the % AluI+ = P1 = % AseI+. However, in all heteroplasmic subclones we observed that % AseI+ ≥ %AluI+, indicating that R′ ≠ 0 and that R′ ≥ R′′. 
